Physician profile

Calvin E Atwell

Surgery · Moline, IL

NPI 1972574028

$7,293.27

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$317.12

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $6,661.41 2019-2023
Medtronic, INC. $180.94 2022-2024 V-Loc 180, Ligasure, Progrip
Stryker Corporation $166.22 2019-2023 1788
Conmed Corporation $129.95 2019-2023 Airseal, Conmed Specimen Retrieval
Zimmer Biomet Holdings, INC. $62.77 2019
Baudax Bio INC. $32.63 2021
Davol INC. $31.25 2019
Covidien Lp $28.10 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Calvin E Atwell

$7,293.27

in general payments reported 2019-2025

Years
2019-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/44241/calvin-e-atwell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.